---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-006310"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2026-02-12T23:59:59+00:00"
generated_at: "2026-05-16T03:10:42.088003+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
confidence: "medium"
source: SEC EDGAR
---

# Microbot Medical's LIBERTY system featured at ISET; gains commercial traction in limited market release

## Summary
- LIBERTY Endovascular Robotic System highlighted at ISET conference Feb 9-12, 2026 in Miami Beach.
- LIBERTY is only FDA-cleared single-use endovascular robotic system; featured in Town Hall session on future of robotics.
- Limited market release commenced late 2025; full market release planned at SIR conference April 2026.
- System used across multiple hospitals for wide range of procedure types including complex cases; interest from multiple specialties.

## SEC filing metadata
- accession: 0001493152-26-006310
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2026-02-12T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000149315226006310/0001493152-26-006310-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000149315226006310/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-006310
- JSON: https://secwatch.observer/filing/0001493152-26-006310.json
- Plain text: https://secwatch.observer/filing/0001493152-26-006310.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.